{
    "2019-07-30": [
        [
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)拟购买漯河煜康及新疆泰睿合计持有的北京雅信诚38%股权",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "北京雅信诚",
                        "股权收购",
                        "漯河煜康",
                        "新疆泰睿"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "临床翻译"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：拟8208万元收购北京雅信诚38%股权 整合临床翻译资源",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "北京雅信诚",
                        "股权收购",
                        "临床翻译",
                        "资源整合"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "临床翻译"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}